Table 1 Baseline demographics and stroke risk factors across treatment group
From: Association between different acute stroke therapies and development of post stroke seizures
|  | IAT + IV-tPA, n = 112 | IAT only n = 93 | IV-tPA only, n = 363 | Control, n = 1375 | p-value |
|---|---|---|---|---|---|
Age (median, IQR) | 70 (59–78) | 67 (54–77) | 74 (65–82) | 62 (52–70) | 0.0001a |
Female Sex (n,%) | 45 (40.2) | 50 (54) | 175 (48.2) | 477 (34.7) | < 0.001b |
Systolic Blood Pressure (median, IQR) | - x | - x | 150 (133–167) | 136 (128–150) | 0.0001a |
Diastolic Blood Pressure (median, IQR) | - x | - x | 80 (70–90) | 80 (72–88) | 0.50a |
NIHSS baseline (median, IQR) | 17 (13–21) | 18 (13–21) | 10 (6–17) | 2 (0–7) | 0.0001a |
Hypertension (n,%) | 66 (58.9) | 42 (45) | 264 (73.0) | 823 (59.8) | < 0.001b |
Diabetes (n,%) | 19 (17.0) | 19 (20.4) | 106 (29.2) | 299 (21.7) | 0.05b |
Dyslipidaemia (n,%) | 33 (29.5) | 28 (30) | 191 (52.6) | 53 (4) | < 0.001b |
Smoking (n,%) | - x | - x | 88 (24) | 438 (32) | 0.001b |
Atrial Fibrillation (n,%) | 43 (38.4) | 31 (33.3) | 115 (31.7) | 114 (8.3) | < 0.001b |
Hemorrhagic Transformation (n,%) | 28 (25) | 28 (30) | 63 (17) | -x | 0.001b |
3-month mRS (0–2) (n,%) | 59 (53) | 36 (39) | 191 (53) | 839 (61) | < 0.001b |
Post Stroke Seizures (n,%) | 5 (4.5) | 12 (12.9) | 21 (5.8) | 28 (2) | < 0.001b |